| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 30.000 MILLIGRAMS PYRIDOSTIGMINE BROMIDE ACTIVE INGREDIENT |
| FEATURES PROVIDED | INDIVIDUALLY SEALED |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | PYRIDOSTIGMINE BROMIDE TABLETS,USP 30MG I.S. 210S PG |
| PRIMARY CONTAINER CONTENT QUANTITY | 21.000 TABLETS |
| PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER | 10 STRIP |
| PRIMARY CONTAINER TYPE | PACKAGE |
| SPECIAL FEATURES | 30MG ACTIVE INGREDIENT; INDIVIDUALLY SEALED, BLISTER OR STRIP PACKAGED; 10 PACKAGES OF 21 TABLETS (210 TABLETS PER PACKAGE); THE BLISTER OR STRIP PACKAGE IS CONTAINED INSIDE A CRUSH PROOF PLASTIC SLEEVE; FOR USE IN NERVE AGENT PRE-TREATMENT STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES CELSIUS OR 68 TO 70 DEGREES FAHRENHEIT. THIS ITEM IS NON-PROCURABLE. |
| SUPPLEMENTARY FEATURES | STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREES CELSIUS OR 68 TO 70 DEGREES FAHRENHEIT. |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| TOTAL SECONDARY CONTAINER QUANTITY | 10 |